Unilever Q3 Sales Up 5.2%, Raises Outlook, But New Price Hikes Weigh on Shares
UL sits 17% above its 52-week low of $54.75.
Summary
Unilever delivered 5.2% underlying sales growth in Q3 on 2.9% volume, with turnover up 6.7% to €13.3bn, and raised its 2026 outlook to 4-6% underlying sales growth with volume growth of at least 3%, up from about 3%. Personal Care (+9.7%), Beauty & Wellbeing (+9.5%) and Home Care (+7.5%) carried the quarter, while Foods turnover was flat and down 2.6% for the nine months — the segment being merged into McCormick next year, with Unilever shareholders retaining a majority of the combined company. Management said it will accelerate price increases in Q4 and into 2027 to offset higher shipping costs, a move that protects margins but risks pushing consumers to cheaper brands; the stock is down for a fourth straight session. The UK competition regulator's September investigation into the $65B McCormick foods merger remains the key overhang on the separation.
At the time of this announcement, UL was trading at $63.86 on NYSE in the Trade & Services sector, with a market capitalization of approximately $140.2B. The 52-week trading range was $54.75 to $74.98. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.